EValuating the Safety Of De-escaLated Head and Neck Irradiation in HPV positivE Oropharynx Cancer in Non-smokers/Minimal Smokers
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03777384|
Recruitment Status : Recruiting
First Posted : December 17, 2018
Last Update Posted : February 20, 2019
|Condition or disease|
This is a prospective, single-site, observational study in head and neck cancer participants. The purpose of this study is to provide a systematic platform to analyze, interpret, and track radiation dose de-escalation therapy and associated participant outcomes from treatments identified by these results.
Participants will be asked to complete quality of life questionnaires at regular time points before, during, and after treatment.
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Official Title:||EValuating the Safety Of De-escaLated Head and Neck Irradiation in HPV positivE Oropharynx Cancer in Non-smokers/Minimal Smokers|
|Actual Study Start Date :||October 12, 2018|
|Estimated Primary Completion Date :||December 2019|
|Estimated Study Completion Date :||December 2023|
- The durability of local disease control of de-escalated radiotherapy protocols in the community cancer center setting. [ Time Frame: End of treatment to 5 years after end of treatment ]Number of participants who remain disease free from the end of treatment to 5 years after treatment.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03777384
|Contact: Colette Freefirstname.lastname@example.org|
|United States, North Dakota|
|Sanford Roger Maris Cancer Center||Recruiting|
|Fargo, North Dakota, United States, 58102|
|Contact: Brittany Bloch 701-234-7563 Brittany.Bloch@SanfordHealth.org|
|Principal Investigator: Miran Blanchard, MD|
|United States, South Dakota|
|Sanford Edith Cancer Center||Recruiting|
|Sioux Falls, South Dakota, United States, 57104|
|Contact: Jeanne Litka 605-312-3328 Jeanne.Litka@sanfordhealth.org|
|Study Chair:||Miran Blanchard, MD||Sanford Health|